These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8158138)

  • 1. Resistance of golden hamster to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: relationship with low levels of regional monoamine oxidase B.
    Mitra N; Mohanakumar KP; Ganguly DK
    J Neurochem; 1994 May; 62(5):1906-12. PubMed ID: 8158138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of mice.
    Giovanni A; Sieber BA; Heikkila RE; Sonsalla PK
    J Pharmacol Exp Ther; 1991 May; 257(2):691-7. PubMed ID: 2033514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain.
    Fuller RW; Robertson DW; Hemrick-Luecke SK
    J Pharmacol Exp Ther; 1987 Feb; 240(2):415-20. PubMed ID: 3100775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced neurotoxicity.
    Mohanakumar KP; Muralikrishnan D; Thomas B
    Brain Res; 2000 May; 864(2):281-90. PubMed ID: 10802035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunity of fetal mice to prenatal administration of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Melamed E; Rosenthal J; Youdim MB
    J Neurochem; 1990 Oct; 55(4):1427-31. PubMed ID: 2398363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance of the golden hamster to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-neurotoxicity is not only related with low levels of cerebral monoamine oxidase-B.
    Rodríguez S; Ito T; He XJ; Uchida K; Nakayama H
    Exp Toxicol Pathol; 2013 Jan; 65(1-2):127-33. PubMed ID: 21795029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial protective effect of MK-801 on MPTP-induced reduction of striatal dopamine in mice.
    Tabatabaei A; Perry TL; Hansen S; Krieger C
    Neurosci Lett; 1992 Jul; 141(2):192-4. PubMed ID: 1436633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
    Aubin N; Barneoud P; Carter C; Caille D; Sontag N; Marc C; Lolivier J; Gardes A; Perron C; Le Kim A; Charieras T; Pandini M; Burnier P; Puech F; Jegham S; George P; Scatton B; Curet O
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1171-82. PubMed ID: 15178694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the possible dopaminergic toxicity of 1-methyl-3-phenyl-1,2,3,6-tetrahydropyridine, an isomer to the neurotoxin MPTP.
    Nilsson K; Hallberg A; Pileblad E; Tunek A
    Pharmacol Toxicol; 1991 Jul; 69(1):38-42. PubMed ID: 1682909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of intra- and extrasynaptosomal monoamine oxidase-A and -B activities in the striatum and frontal cortex of two mice strains with different sensitivities to the neurotoxic actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Stenström A; Sundström E; Fowler CJ
    Pharmacol Toxicol; 1989 Mar; 64(3):276-81. PubMed ID: 2786196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in nigral neuron number and sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57/bl and CD-1 mice.
    Muthane U; Ramsay KA; Jiang H; Jackson-Lewis V; Donaldson D; Fernando S; Ferreira M; Przedborski S
    Exp Neurol; 1994 Apr; 126(2):195-204. PubMed ID: 7925820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors.
    Heikkila RE; Manzino L; Cabbat FS; Duvoisin RC
    Nature; 1984 Oct 4-10; 311(5985):467-9. PubMed ID: 6332989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MPTP toxicity in relation to age, dopamine uptake and MAO-B activity in two rodent species.
    Jossan SS; Sakurai E; Oreland L
    Pharmacol Toxicol; 1989 Mar; 64(3):314-8. PubMed ID: 2786198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different susceptibility to 1-methyl-4-phenylpyridium (MPP(+))-induced nigro-striatal dopaminergic cell loss between C57BL/6 and BALB/c mice is not related to the difference of monoamine oxidase-B (MAO-B).
    Ito T; Suzuki K; Uchida K; Nakayama H
    Exp Toxicol Pathol; 2013 Jan; 65(1-2):153-8. PubMed ID: 21855308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the biological activity of several analogs of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Youngster SK; Sonsalla PK; Heikkila RE
    J Neurochem; 1987 Mar; 48(3):929-34. PubMed ID: 3492590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strain differences in systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in mice correlate best with monoamine oxidase activity at the blood-brain barrier.
    Riachi NJ; Harik SI
    Life Sci; 1988; 42(23):2359-63. PubMed ID: 3259663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex-related effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine treatment may be related to differences in monoamine oxidase B.
    Unzeta M; Baron S; Perez V; Ambrosio S; Mahy N
    Neurosci Lett; 1994 Aug; 176(2):235-8. PubMed ID: 7830954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevation of neuronal MAO-B activity in a transgenic mouse model does not increase sensitivity to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Andersen JK; Frim DM; Isacson O; Beal MF; Breakefield XO
    Brain Res; 1994 Sep; 656(1):108-14. PubMed ID: 7804823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difference in monoamine oxidase B activity between C57 black and albino NMRI mouse strains may explain differential effects of the neurotoxin MPTP.
    Zimmer J; Geneser FA
    Neurosci Lett; 1987 Aug; 78(3):253-8. PubMed ID: 3498133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of types A and B monoamine oxidase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Fuller RW; Hemrick-Luecke SK
    J Pharmacol Exp Ther; 1985 Mar; 232(3):696-701. PubMed ID: 3871853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.